ADCSFDAFDABiologicAstellasvedotin plus pembrolizumab …Approved
enfortumab vedotin (Padcev)
Metastatic Bladder Urothelial Carcinoma; Metastatic Renal Pelvis and Ureter Urothelial Carcinoma · Renal Pelvis and Ureter Urothelial Carci
#RenalPelvisandUreterUrothelialCa#ADC#Approved#FDA승인#인기+5
효능 ORR 44%임상시험 76상태 RECRUITING